info@seagull-health.com
SeagullHealth
语言:
search

Who can use Ongentys(Opicapone)?

A description of the medical conditions for which the drug is approved.

Therapeutic Use

ONGENTYS is indicated as an adjunctive therapy to levodopa/carbidopa for patients diagnosed with Parkinson's disease who are experiencing "off" episodes. These episodes are characterized by the return of Parkinsonian symptoms despite medication. It is specifically used to reduce the duration of these "off" periods and is intended for use in conjunction with the standard levodopa/carbidopa regimen.

Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
WeChat Scan
Free Inquiry
Related articles
What Are the Indications for Opicapone (Ongentys)?
Opicapone (Ongentys) is a novel, peripherally selective and reversible catechol-O-methyltransferase (COMT) inhibitor. It was approved for marketing by the U.S. Food and Drug Administration (FDA) in 20...
共 1 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved